Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 614 entries
Sorted by: Best Match Show Resources per page
Gastric secretion.

Current opinion in gastroenterology

Schubert ML.
PMID: 17031123
Curr Opin Gastroenterol. 2000 Nov;16(6):463-8. doi: 10.1097/00001574-200011000-00002.

This article summarizes data published during the past year that improve our understanding of the mechanisms by which various neurotransmitters, paracrine agents, and hormones regulate gastric acid secretion and are themselves regulated. The main stimulants of acid secretion are...

Cite
Schubert ML. Gastric secretion. Curr Opin Gastroenterol. 2000;16(6):463-8doi: 10.1097/00001574-200011000-00002.
Schubert, M. L. (2000). Gastric secretion. Current opinion in gastroenterology, 16(6), 463-8. https://doi.org/10.1097/00001574-200011000-00002
Schubert, M L. "Gastric secretion." Current opinion in gastroenterology vol. 16,6 (2000): 463-8. doi: https://doi.org/10.1097/00001574-200011000-00002
Schubert ML. Gastric secretion. Curr Opin Gastroenterol. 2000 Nov;16(6):463-8. doi: 10.1097/00001574-200011000-00002. PMID: 17031123.
Copy Download .nbib Format: NLM
Treatment of Functional Dyspepsia.

Current treatment options in gastroenterology

Delgado-Aros S, Cremonini F, Talley NJ.
PMID: 15010026
Curr Treat Options Gastroenterol. 2004 Apr;7(2):121-131. doi: 10.1007/s11938-004-0033-1.

Functional dyspepsia is a common chronic condition. It can have a major impact on quality of life and remains a large burden on healthcare resources. Its underlying mechanisms are not fully understood and therapies are mainly empirical. In this...

Cite
Delgado-Aros S, Cremonini F, Talley NJ. Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol. 2004;7(2):121-131doi: 10.1007/s11938-004-0033-1.
Delgado-Aros, S., Cremonini, F., & Talley, N. J. (2004). Treatment of Functional Dyspepsia. Current treatment options in gastroenterology, 7(2), 121-131. https://doi.org/10.1007/s11938-004-0033-1
Delgado-Aros, Silvia, et al. "Treatment of Functional Dyspepsia." Current treatment options in gastroenterology vol. 7,2 (2004): 121-131. doi: https://doi.org/10.1007/s11938-004-0033-1
Delgado-Aros S, Cremonini F, Talley NJ. Treatment of Functional Dyspepsia. Curr Treat Options Gastroenterol. 2004 Apr;7(2):121-131. doi: 10.1007/s11938-004-0033-1. PMID: 15010026.
Copy Download .nbib Format: NLM
Receptor biology and signal transduction in pancreatic acinar cells.

Current opinion in gastroenterology

Bi Y, Williams JA.
PMID: 15689674
Curr Opin Gastroenterol. 2004 Sep;20(5):427-34. doi: 10.1097/00001574-200409000-00002.

PURPOSE OF REVIEW: Secretagogue receptors and their intracellular signaling pathways regulate pancreatic physiology and may be altered in pathophysiology. Therefore, understanding of the continued progress into their nature and function is relevant to both biology and disease.RECENT FINDINGS: The...

Cite
Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr Opin Gastroenterol. 2004;20(5):427-34doi: 10.1097/00001574-200409000-00002.
Bi, Y., & Williams, J. A. (2004). Receptor biology and signal transduction in pancreatic acinar cells. Current opinion in gastroenterology, 20(5), 427-34. https://doi.org/10.1097/00001574-200409000-00002
Bi, Yan, and Williams, John A. "Receptor biology and signal transduction in pancreatic acinar cells." Current opinion in gastroenterology vol. 20,5 (2004): 427-34. doi: https://doi.org/10.1097/00001574-200409000-00002
Bi Y, Williams JA. Receptor biology and signal transduction in pancreatic acinar cells. Curr Opin Gastroenterol. 2004 Sep;20(5):427-34. doi: 10.1097/00001574-200409000-00002. PMID: 15689674.
Copy Download .nbib Format: NLM
Gallbladder dyskinesia.

Current treatment options in gastroenterology

Hansel SL, Dibaise JK.
PMID: 18321434
Curr Treat Options Gastroenterol. 2008 Apr;11(2):78-84. doi: 10.1007/s11938-008-0019-5.

The most appropriate means to diagnose and manage patients with suspected gallbladder dyskinesia remain contentious. A major problem relates to difficulties in clearly identifying the features that characterize biliary-like pain. Conflicting reports in the literature regarding whether symptoms alone...

Cite
Hansel SL, Dibaise JK. Gallbladder dyskinesia. Curr Treat Options Gastroenterol. 2008;11(2):78-84doi: 10.1007/s11938-008-0019-5.
Hansel, S. L., & Dibaise, J. K. (2008). Gallbladder dyskinesia. Current treatment options in gastroenterology, 11(2), 78-84. https://doi.org/10.1007/s11938-008-0019-5
Hansel, Stephanie L, and Dibaise, John K. "Gallbladder dyskinesia." Current treatment options in gastroenterology vol. 11,2 (2008): 78-84. doi: https://doi.org/10.1007/s11938-008-0019-5
Hansel SL, Dibaise JK. Gallbladder dyskinesia. Curr Treat Options Gastroenterol. 2008 Apr;11(2):78-84. doi: 10.1007/s11938-008-0019-5. PMID: 18321434.
Copy Download .nbib Format: NLM
Laparoscopic cholecystectomy for acalculous gallbladder disease.

Proceedings (Baylor University. Medical Center)

Fuller RA, Kuhn JA, Fisher TL, Newsome TW, Smith BA, Jones RC.
PMID: 16389335
Proc (Bayl Univ Med Cent). 2000 Oct;13(4):331-3. doi: 10.1080/08998280.2000.11927698.

Use of laparoscopic cholecystectomy (LC) to treat patients with symptoms due to gallstone disease is well established. However, use of LC for patients with acalculous gallbladder disease remains controversial. In this study, we examined the use of hepatobiliary iminodiacetic...

Cite
Fuller RA, Kuhn JA, Fisher TL, et al. Laparoscopic cholecystectomy for acalculous gallbladder disease. Proc (Bayl Univ Med Cent). 2000;13(4):331-3doi: 10.1080/08998280.2000.11927698.
Fuller, R. A., Kuhn, J. A., Fisher, T. L., Newsome, T. W., Smith, B. A., & Jones, R. C. (2000). Laparoscopic cholecystectomy for acalculous gallbladder disease. Proceedings (Baylor University. Medical Center), 13(4), 331-3. https://doi.org/10.1080/08998280.2000.11927698
Fuller, R A, et al. "Laparoscopic cholecystectomy for acalculous gallbladder disease." Proceedings (Baylor University. Medical Center) vol. 13,4 (2000): 331-3. doi: https://doi.org/10.1080/08998280.2000.11927698
Fuller RA, Kuhn JA, Fisher TL, Newsome TW, Smith BA, Jones RC. Laparoscopic cholecystectomy for acalculous gallbladder disease. Proc (Bayl Univ Med Cent). 2000 Oct;13(4):331-3. doi: 10.1080/08998280.2000.11927698. PMID: 16389335; PMCID: PMC1312225.
Copy Download .nbib Format: NLM
Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders.

Expert opinion on investigational drugs

D'Amato M, Rovati LC.
PMID: 15989644
Expert Opin Investig Drugs. 1997 Jul;6(7):819-36. doi: 10.1517/13543784.6.7.819.

Cholecystokinin (CCK) is a peptide that exerts several regulatory functions in the periphery, as well as in the brain. The biological functions attributed to CCK are mediated by two receptor subtypes, termed CCKA and CCKB, located predominantly in the...

Cite
D'Amato M, Rovati LC. Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders. Expert Opin Investig Drugs. 1997;6(7):819-36doi: 10.1517/13543784.6.7.819.
D'Amato, M., & Rovati, L. C. (1997). Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders. Expert opinion on investigational drugs, 6(7), 819-36. https://doi.org/10.1517/13543784.6.7.819
D'Amato, M, and Rovati, L C. "Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders." Expert opinion on investigational drugs vol. 6,7 (1997): 819-36. doi: https://doi.org/10.1517/13543784.6.7.819
D'Amato M, Rovati LC. Cholecystokinin-A receptor antagonists: therapies for gastrointestinal disorders. Expert Opin Investig Drugs. 1997 Jul;6(7):819-36. doi: 10.1517/13543784.6.7.819. PMID: 15989644.
Copy Download .nbib Format: NLM
Investigational drugs for eating disorders.

Expert opinion on investigational drugs

Crow S.
PMID: 15989610
Expert Opin Investig Drugs. 1997 Apr;6(4):427-36. doi: 10.1517/13543784.6.4.427.

Anorexia nervosa (AN), bulimia nervosa (BN) and binge eating disorder (BED) each occur in about 0.5-1.5% of the population in westernised countries, and primarily affect women. At present, a variety of pharmacological treatments are used in addition to psychotherapy,...

Cite
Crow S. Investigational drugs for eating disorders. Expert Opin Investig Drugs. 1997;6(4):427-36doi: 10.1517/13543784.6.4.427.
Crow, S. (1997). Investigational drugs for eating disorders. Expert opinion on investigational drugs, 6(4), 427-36. https://doi.org/10.1517/13543784.6.4.427
Crow, S. "Investigational drugs for eating disorders." Expert opinion on investigational drugs vol. 6,4 (1997): 427-36. doi: https://doi.org/10.1517/13543784.6.4.427
Crow S. Investigational drugs for eating disorders. Expert Opin Investig Drugs. 1997 Apr;6(4):427-36. doi: 10.1517/13543784.6.4.427. PMID: 15989610.
Copy Download .nbib Format: NLM
Treatment of functional dyspepsia.

Current treatment options in gastroenterology

Halder SL, Talley NJ.
PMID: 16009034
Curr Treat Options Gastroenterol. 2005 Aug;8(4):325-36. doi: 10.1007/s11938-005-0026-8.

Functional dyspepsia (FD) is a common reason a patient presents with upper gastrointestinal symptoms for medical care. Although treatment of FD remains expensive, the agents are rarely used in a systematic manner; the majority of treatments are empirical and...

Cite
Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005;8(4):325-36doi: 10.1007/s11938-005-0026-8.
Halder, S. L., & Talley, N. J. (2005). Treatment of functional dyspepsia. Current treatment options in gastroenterology, 8(4), 325-36. https://doi.org/10.1007/s11938-005-0026-8
Halder, Smita L S, and Talley, Nicholas J. "Treatment of functional dyspepsia." Current treatment options in gastroenterology vol. 8,4 (2005): 325-36. doi: https://doi.org/10.1007/s11938-005-0026-8
Halder SL, Talley NJ. Treatment of functional dyspepsia. Curr Treat Options Gastroenterol. 2005 Aug;8(4):325-36. doi: 10.1007/s11938-005-0026-8. PMID: 16009034.
Copy Download .nbib Format: NLM
Small intestinal motility.

Current opinion in gastroenterology

Smout AJ.
PMID: 15703625
Curr Opin Gastroenterol. 2004 Mar;20(2):77-81. doi: 10.1097/00001574-200403000-00005.

PURPOSE OF REVIEW: In the past year, many studies were published in which new and relevant information on small intestinal motility in humans and laboratory animals was obtained.RECENT FINDINGS: Although the reported findings are heterogeneous, some themes appear to...

Cite
Smout AJ. Small intestinal motility. Curr Opin Gastroenterol. 2004;20(2):77-81doi: 10.1097/00001574-200403000-00005.
Smout, A. J. (2004). Small intestinal motility. Current opinion in gastroenterology, 20(2), 77-81. https://doi.org/10.1097/00001574-200403000-00005
Smout, André J P M. "Small intestinal motility." Current opinion in gastroenterology vol. 20,2 (2004): 77-81. doi: https://doi.org/10.1097/00001574-200403000-00005
Smout AJ. Small intestinal motility. Curr Opin Gastroenterol. 2004 Mar;20(2):77-81. doi: 10.1097/00001574-200403000-00005. PMID: 15703625.
Copy Download .nbib Format: NLM
Cholecystokinin Activity of Urine.

Science (New York, N.Y.)

Svatos A.
PMID: 17733646
Science. 1959 Feb 27;129(3348):567-8. doi: 10.1126/science.129.3348.567.

In the urine of men and animals was found a factor which evokes the contraction of the gall bladder. This factor increases in the urine after the application of a secretogenous stimulus to the duodenum and decreases after resection...

Cite
Svatos A. Cholecystokinin Activity of Urine. Science. 1959;129(3348):567-8doi: 10.1126/science.129.3348.567.
Svatos, A. (1959). Cholecystokinin Activity of Urine. Science (New York, N.Y.), 129(3348), 567-8. https://doi.org/10.1126/science.129.3348.567
Svatos, A. "Cholecystokinin Activity of Urine." Science (New York, N.Y.) vol. 129,3348 (1959): 567-8. doi: https://doi.org/10.1126/science.129.3348.567
Svatos A. Cholecystokinin Activity of Urine. Science. 1959 Feb 27;129(3348):567-8. doi: 10.1126/science.129.3348.567. PMID: 17733646.
Copy Download .nbib Format: NLM
Duodenal implications in the pathophysiology of functional dyspepsia.

Journal of neurogastroenterology and motility

Lee KJ, Tack J.
PMID: 20680163
J Neurogastroenterol Motil. 2010 Jul;16(3):251-7. doi: 10.5056/jnm.2010.16.3.251. Epub 2010 Jul 26.

Functional dyspepsia (FD) is a heterogeneous disorder associated with diverse pathophysiologic mechanisms. Studies have shown duodenal implications in the pathophysiology of FD. Duodenal hypersensitivity to acid, increased duodenal acid exposure, and abnormal responses to duodenal lipids or released cholecystokinin...

Cite
Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010;16(3):251-7doi: 10.5056/jnm.2010.16.3.251.
Lee, K. J., & Tack, J. (2010). Duodenal implications in the pathophysiology of functional dyspepsia. Journal of neurogastroenterology and motility, 16(3), 251-7. https://doi.org/10.5056/jnm.2010.16.3.251
Lee, Kwang Jae, and Tack, Jan. "Duodenal implications in the pathophysiology of functional dyspepsia." Journal of neurogastroenterology and motility vol. 16,3 (2010): 251-7. doi: https://doi.org/10.5056/jnm.2010.16.3.251
Lee KJ, Tack J. Duodenal implications in the pathophysiology of functional dyspepsia. J Neurogastroenterol Motil. 2010 Jul;16(3):251-7. doi: 10.5056/jnm.2010.16.3.251. Epub 2010 Jul 26. PMID: 20680163; PMCID: PMC2912117.
Copy Download .nbib Format: NLM
The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat.

International journal of clinical and experimental medicine

Katanyutanon S, Wu R, Wang P.
PMID: 19079678
Int J Clin Exp Med. 2008;1(4):332-7. Epub 2008 Oct 15.

Radiation-induced injury may occur in various incidents as well as the terrorist radiation exposure scenario. The digestive tract is among the most radiosensitive organs in the body and its function, which is partly regulated by gastrointestinal (GI) peptides, can...

Cite
Katanyutanon S, Wu R, Wang P. The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat. Int J Clin Exp Med. 2008;1(4):332-7
Katanyutanon, S., Wu, R., & Wang, P. (2008). The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat. International journal of clinical and experimental medicine, 1(4), 332-7.
Katanyutanon, Sakdhisapol, et al. "The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat." International journal of clinical and experimental medicine vol. 1,4 (2008): 332-7.
Katanyutanon S, Wu R, Wang P. The effect of whole-body radiation on blood levels of gastrointestinal peptides in the rat. Int J Clin Exp Med. 2008;1(4):332-7. Epub 2008 Oct 15. PMID: 19079678; PMCID: PMC2596326.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 614 entries